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ABSTRACT
Introduction. In the coming decades, the population of adults 65 years of age and older will increase 
significantly. Younger patients between 30 and 40 years of age, who are diagnosed with cervical cancer, 
have a better prognosis than the older group. The second peak of incidence, involving patients between 
60 and 70 years of age, correlates with a poorer prognosis.
Material and methods. In our study, we included 360 patients between 40 and 60 years old operated on due 
to cervical cancer followed by radiochemotherapy. We divided these patients into two groups according to 
age. The first group was composed of premenopausal patients (aged between 40 and 50 years) and the 
second of postmenopausal patients (aged between 50 and 60 years), and long-term outcomes (overall 
survival rates OS) were analysed in both groups of patients.
Results. We observed statistically significant differences in the long-term outcomes between the sub-
groups of patients treated surgically for cervical cancer, and it was better in the premenopausal group 
of patients. No statistically significant relationship between these two groups of patients as far as clinical 
features was observed.
Conclusion. We found that postmenopausal patients may actually benefit more from having radical sur-
gery. Proving this supports the case for distinguishing geriatric oncology from gynaecological oncology.
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Introduction
In the coming decades, the population of adults 
65 years of age and older will increase significantly [1]. 
As the number of elderly patients (and along with it, the 
number of postmenopausal patients) is increasing from 
day to day, the current model of medical care will have 
to change to adapt to the aging population. In clinical 
practice, two groups of patients with cervical cancer are 
observed [2]. First, are the women under 40 years old 
who are sexually active with high exposure to cervical 
cancer risk factors, such as a high number of partners, 
cigarette smoking, and lower socioeconomic condi-
tions. The second group comprises an older group of 
patients, the majority of whom are postmenopausal. 
Usually these patients have had previous surgical in-
tervention, such as conisation or some of the ablation 
methods (cryotherapy, laser therapy, or other types 
of therapies), due to intraepithelial neoplasm. Among 
patients with cervical cancer, the different peaks of inci-
dence correlate with differences in prognosis. Younger 
patients between 30 and 40 years of age who are di-
agnosed with cervical cancer have a better prognosis 
than the older group. The second peak of incidence, 
involving patients between 60 and 70 years of age, 
correlates with a poorer prognosis [3]. 
The long-term outcome of cervical cancer treatment 
is still insufficient. Nogueira-Rodrigues et al. presented 
the results of treatment for a large group of patients, in-
cluding 1339 younger patients and 143 elderly patients, 
treated for cervical cancer. The overall five-year survival 
rate among the younger patients was 58.2%, and 48.5% 
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among the older patients (including all stages from 
FIGO I to IV) [3]. Nevertheless, most of our patients are 
diagnosed as LACC. In particular, the poorer prognosis 
found in older as compared to younger women seems 
to be related to a more advanced stage of the disease 
at the time of diagnosis [3]. Unfortunately, a widespread 
mass screening program for cervical cancer has not 
yet been instituted in all countries, and this fact may 
impact the long-term outcomes in postmenopausal 
and elderly women. Another factor, which may also 
influence the long-term outcome in older patients, is 
the method of treatment. Postmenopausal and elderly 
patients with cervical cancer are more often treated 
using radiotherapy than surgery or radio-chemother-
apy [3]. Generally, it is thought that surgery in elderly 
patients is linked with a greater number of subsequent 
complications. Although elderly patients with uterine 
cervical cancer reportedly have a  poorer prognosis 
than younger patients, the group of postmenopausal 
patients in whom the poorer prognosis is related to 
comorbidity secondary to the age of the patient needs 
to be more precisely distinguished from the group of 
women who may benefit from radical surgery followed 
by radiotherapy. Although cervical cancer is more 
common in young women, it is certainly present in 
postmenopausal and elderly women [4]. Furthermore, 
while the incidence of cervical cancer among younger 
patients has decreased, the proportion of patients di-
agnosed who are over 70 years of age has remained 
stable (near 18%) [2].
The aim of our study was to investigate whether 
postmenopausal patients benefit more from radical 
surgery. 
Material and methods
In our study, we included 360 patients between 
40 and 60 years old operated on due to cervical cancer. 
We divided these patients into two groups according to 
age. The first group was composed of premenopausal 
patients (aged between 40 and 50 years), and the sec-
ond group was composed of postmenopausal patients 
(aged between 50 and 60 years); long-term outcomes 
(overall survival rates OS) in both groups of patients 
were analysed.
Most of these patients (95%) were operated on at 
the beginning of therapy prior to adjuvant radiochemo-
therapy. These patients were treated at the Lukaszczyk 
Oncological Center in Bydgoszcz between 2008 and 
2012. We retrospectively evaluated the series of women. 
The surgical procedure performed consisted of radical 
hysterectomy with lymphadenectomy. The database of 
the Kujawsko-Pomorski regional office of the National 
Health System of Poland provided the data on overall 
survival rates. 
Adjuvant radiochemotherapy was used for cases 
with high-risk prognostic factors, including tumour size 
(> 4 cm), parametrial invasion, and lymph node meta-
stasis. Radiotherapy was performed using whole pelvis 
external beam radiation (59.4 Gy in 28 fractions), and 
chemotherapy consisted of a platinum-based regimen 
administered for four to six cycles. 
Results
We observed statistically significant differences in 
the long-term outcomes between the subgroups of 
patients treated surgically for cervical cancer. Specifi-
cally, we observed a poorer prognosis in the patients 
between 40 and 50 years of age and a better prognosis 
in the patients between 50 and 60 years of age (Fig. 1).
No statistically significant relationship between these 
two groups of patients as far as clinical features, such 
as initial stage of the disease, grading, or histological 
type, was observed. Similarly, the proportion of patients 
treated by surgery alone or surgery followed by radio-
therapy did not differ in the examined patients (Tab. 1).
Discussion
We found that the postmenopausal patients treated 
for gynaecological cancer have a better prognosis than 
premenopausal patients.
Generally, gynaecological malignancy correlates 
with survival rate. Mortality rates depend upon age, and 
Figure 1. Statistically significant differences in the long- 
-term outcomes between the subgroups of patients treated 
surgically for cervical cancer (p < 0.0001) depending on 
age, older or younger than 50 years
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Table 1. Clinical features, such as initial stage of the 
disease (FIGO), grading, or histological type depending 
on age of the patients: older or younger than 50 years
Clinical feature Age
40–50 years
n = 151
50–60 years
n = 209
IA 11 7 12 6
IB 120 79 180 86
IIA 20 16 17 8
Carcinoma planoepitheliale 140 92 198 94
Adenocarcinoma 10 6 8 4
Carcinoma adenosquamous 1 2 1 0.5
Sarcoma 0 0 2 1.5
G1 15 10 16 7.5
G2 100 66 149 71
G3 36 24 44 21.5
a poorer prognosis is observed in elderly patients. The 
majority of studies compare the long-term outcomes 
between elderly and young patients. The mortality rates 
of patients treated for cervical cancer who are more than 
70 years old are typically 2–3-fold higher in comparison 
to younger women [2]. A  few studies distinguished 
the group of women treated for cervical cancer more 
precisely. For instance, Sharma et al. assessed a large 
group of patients with FIGO stage IB1–IIA (28 902), 
who were stratified by age: < 50, 50 to 59, 60 to 69, 
70 to 79, and ≥ 80 years. They observed differences in 
applied therapy relative to the age of the patient. Surgery 
was most preferably used in patients who were under 
50 years of age. More specifically, lymphadenectomy 
was performed in 66.8% of women < 50 years old versus 
9.1% of patients ≥ 80 years old, who instead underwent 
an analogically radical hysterectomy. In advanced stag-
es, the usage of brachytherapy decreased according to 
age. Elderly women with cervical cancer are not treated 
as radically as younger patients. The differences start 
to be measurable at about 50 years of age (surgery is 
less radical, followed by adjuvant radiation or application 
of brachytherapy) [4]. The authors suggested that the 
cancer-specific mortality rate is higher in older women, 
even when the influence on overall survival rate related to 
the applied treatment is not taken into consideration [4]. 
However, in analysing patients who were younger 
or older than 70 years of age, the authors observed 
the following relationship: elderly patients have more 
advanced disease at the time of diagnosis, and this is 
the factor most indicative of a poorer prognosis. On the 
other hand, age is an important factor in the allocation 
of treatment, which also influences overall survival [3]. 
The classification of the patient for adequate radical 
therapy is crucial for improving survival. 
Nosaka et al. reported that concurrent chemora-
diotherapy may be useful in the treatment of cervical 
cancer patients and is well tolerated in the elderly. The 
authors examined two groups of patients. The first 
group included women from 70 to 77 years of age, and 
the second included those from 70 to 89. The median 
overall survival rates were comparable between the two 
groups (66.9 and 60.1 months, retrospectively). Howev-
er, the profile of toxicities related to the applied therapy 
differed between older and younger cervical cancer pa-
tients. The most common was hyponatraemia, followed 
by neutropaenia and diarrhoea [5]. Furthermore, it was 
suggested that geriatric patients with stage I or II cervical 
carcinoma may benefit from radical surgery followed by 
radiotherapy [6]. Similarly, Lin et al. demonstrated that 
patients older than 75 years may be treated curatively 
with radiotherapy [7]. In our group of patients, we found 
that patients just beyond menopause, between 50 and 
60 years of age, may also benefit from radical surgery 
and have even better long-term outcomes than patients 
between 40 and 50 years of age.
Since the poorer prognosis in elderly patients is 
a result, as was mentioned above, of a more advanced 
stage of the disease at the time of diagnosis, the 
screening program must also be used in these pa-
tients. Cakmak et al. presented their results from a study 
of 661 women participating in cervical cancer screening. 
The patients were divided into two groups. The first 
comprised postmenopausal patients between 45 and 
64 years of age, and the second consisted of elderly pa-
tients over 65 years old. Cytological abnormalities have 
often been found to be statistically significantly in elderly 
patients. Although the cervical screening program is 
not usually continuous in elderly patients, squamous 
intraepithelial lesions can still be encountered in this 
group, which definitely requires greater attention when 
it comes to gynaecological care [8]. A cancer screening 
program is an important tool for decreasing morbidity 
and mortality rates even among the elderly [9].
It is understood that the number of deaths is related 
to the total number of patients, and that the number of 
these patients who are postmenopausal is greater than 
those who are premenopausal. The two groups there-
fore differ when it comes to overall survival rates. This 
fact supports the hypothesis that we should correlate 
the type of therapy we apply with the age of the patient, 
not only because of organ efficiency or haemostatic 
condition, but also because of the biology of the neo-
plasm itself. Older patients need different standards of 
treatment beyond just a reduction in dose relative to 
age. Based on the outcomes obtained, we also need 
to start to distinguish geriatric oncology from gynaeco-
logical oncology. 
In summary, we chose cervical cancer patients for 
our analysis of the potential influences of the range of 
surgery on treatment outcomes according to age. We 
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found that postmenopausal patients may benefit more 
from having radical surgery. Proving this supports the 
case for distinguishing geriatric oncology from gynae-
cological oncology.
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